Informationen:
Fehler:
ID
34825
Beschreibung
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02461602
Link
https://clinicaltrials.gov/show/NCT02461602
Stichworte
Versionen (1)
- 30.01.19 30.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
30. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Atrial Fibrillation NCT02461602
Eligibility Atrial Fibrillation NCT02461602
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Atrial Fibrillation NCT02461602
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
18 years or older at the time of enrollment
boolean
C0001779 (UMLS CUI [1])
Atrial Fibrillation Electrocardiography
Item
electrocardiographically confirmed af
boolean
C0004238 (UMLS CUI [1,1])
C1623258 (UMLS CUI [1,2])
C1623258 (UMLS CUI [1,2])
Surveys Completion
Item
able to complete patient-reported outcomes surveys
boolean
C0038951 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])
Warfarin therapy started
Item
initiated warfarin therapy in the prior 3 months
boolean
C0419974 (UMLS CUI [1])
Adherence Clinic Visits
Item
ability to adhere to regular clinical visits
boolean
C1510802 (UMLS CUI [1,1])
C0008952 (UMLS CUI [1,2])
C0008952 (UMLS CUI [1,2])
Informed Consent
Item
ability to sign informed consent
boolean
C0021430 (UMLS CUI [1])
Able to read English Language | Comprehension English Language | Able to speak English Language
Item
ability to read/comprehend/speak english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0564215 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
C0376245 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0564215 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Life Expectancy
Item
anticipated life expectancy less than six months (as determined by the site investigator)
boolean
C0023671 (UMLS CUI [1])
Atrial Fibrillation Transient | Secondary to Condition Reversible | Hyperthyroidism | Pulmonary Embolism | Status post Cardiothoracic surgery
Item
transient af secondary to a reversible condition (hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
boolean
C0004238 (UMLS CUI [1,1])
C0205374 (UMLS CUI [1,2])
C0175668 (UMLS CUI [2,1])
C0348080 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
C0020550 (UMLS CUI [3])
C0034065 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2242990 (UMLS CUI [5,2])
C0205374 (UMLS CUI [1,2])
C0175668 (UMLS CUI [2,1])
C0348080 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
C0020550 (UMLS CUI [3])
C0034065 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2242990 (UMLS CUI [5,2])
Deep Vein Thrombosis | Pulmonary Embolism
Item
recent dvt or pe (within 6 months)
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
C0034065 (UMLS CUI [2])
Study Subject Participation Status | Anticoagulation Therapy Atrial Fibrillation
Item
participation in a randomized trial of anticoagulation for af
boolean
C2348568 (UMLS CUI [1])
C0003281 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
C0003281 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
Use of Home INR Monitoring Services
Item
use of a home inr monitoring system
boolean
C1524063 (UMLS CUI [1,1])
C4523608 (UMLS CUI [1,2])
C4523608 (UMLS CUI [1,2])